106 related articles for article (PubMed ID: 1247837)
1. Changes in immune status in patients undergoing splenectomy for the staging of Hodgkin's disease.
Hancock BW; Bruce L; Ward AM; Richmond J
Br Med J; 1976 Feb; 1(6005):313-5. PubMed ID: 1247837
[TBL] [Abstract][Full Text] [Related]
2. Immunity in Hodgkin's disease: status after 5 years' remission.
Hancock BW; Bruce L; Whitham MD; Dunsmore IR; Ward AM; Richmond J
Br J Cancer; 1982 Oct; 46(4):593-600. PubMed ID: 7138765
[TBL] [Abstract][Full Text] [Related]
3. Long-term influence of splenectomy on immune functions in patients with Hodgkin's disease.
Björkholm M; Askergren J; Holm G; Mellstedt H
Scand J Haematol; 1980 Jan; 24(1):87-94. PubMed ID: 6966069
[TBL] [Abstract][Full Text] [Related]
4. Serum immunoglobulin levels in splenectomized Hodgkin patients and in subjects following post-traumatic splenectomy.
Douer D; Chaimoff C; Pick AI; Pinkhas J
Oncology; 1981; 38(3):165-7. PubMed ID: 7207953
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease.
van Rijswijk RE; Sybesma JP; Kater L
Cancer; 1984 Jan; 53(1):62-9. PubMed ID: 6690004
[TBL] [Abstract][Full Text] [Related]
6. Serum immunoglobulin levels in childhood Hodgkin's disease. Effect of splenectomy and long-term follow-up.
Walzer PD; Armstrong D; Weisman P; Tan C
Cancer; 1980 Apr; 45(8):2084-9. PubMed ID: 7370954
[TBL] [Abstract][Full Text] [Related]
7. Impaired humoral immunity in treated Hodgkin's disease.
Weitzman SA; Aisenberg AC; Siber GR; Smith DH
N Engl J Med; 1977 Aug; 297(5):245-8. PubMed ID: 301608
[TBL] [Abstract][Full Text] [Related]
8. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
Steele R; Han T
Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
[TBL] [Abstract][Full Text] [Related]
9. [Long term effects of splenectomy on the immune-status of Hodgkin's disease patients depending on the modality of treatment (author's transl)].
Schaadt M; Diehl V; Kalden JR; Schmidt N; Laskewitz E
Med Klin; 1978 Oct; 73(40):1381-8. PubMed ID: 309061
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of serum innumoglobulin levels in Hodgkin's disease.
Alsabti EA; Shaheen A
Neoplasma; 1979; 26(3):329-33. PubMed ID: 530336
[TBL] [Abstract][Full Text] [Related]
11. Increase of T lymphocytes in the spleen in Hodgkin's disease.
Kaur J; Spiers AS; Catovsky D; Galton DA
Lancet; 1974 Oct; 2(7884):800-2. PubMed ID: 4138221
[No Abstract] [Full Text] [Related]
12. The influence of splenectomy on cellular immunologic parameters in Hodgkin's disease.
Wagener DJ; Geestman E; Borgonjen A; Haanen C
Cancer; 1976 May; 37(5):2212-9. PubMed ID: 130968
[TBL] [Abstract][Full Text] [Related]
13. Follow-up studies on the immune status of patients with Hodgkin's disease after splenectomy and treatment, in relapse and remission.
Hancock BW; Bruce L; Dunsmore IR; Ward AM; Richmond J
Br J Cancer; 1977 Sep; 36(3):347-54. PubMed ID: 921891
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of the changes in the immune status before, during, and after multiple-agent chemotherapy for Hodgkin's disease.
Van Rijswijk RE; Sybesma JP; Kater L
Cancer; 1983 Feb; 51(4):637-44. PubMed ID: 6821837
[TBL] [Abstract][Full Text] [Related]
15. [Level of circulating immune complexes in lymphogranulomatosis patients as a criterion of the status and prognosis of the disease].
Savina NP
Ter Arkh; 1986; 58(9):60-4. PubMed ID: 3787494
[TBL] [Abstract][Full Text] [Related]
16. [Immunglobulins G, A, M, and E in lymphogranulomatosis (author's transl)].
Steidle C; Fateh-Moghadam A; Lamerz R; Huhn D; Ehrhart H
MMW Munch Med Wochenschr; 1976 Apr; 118(16):503-8. PubMed ID: 818517
[TBL] [Abstract][Full Text] [Related]
17. The influence of splenectomy, radiotherapy and chemotherapy on the immune response in Hodgkin's disease.
Van Rijswijk RE; Sybesma JP; Kuipers JT; Zegers BJ; Borst-Eilers E
Neth J Med; 1976; 19(4-5):201-8. PubMed ID: 980188
[No Abstract] [Full Text] [Related]
18. Increased serum IgE in Hodgkin's disease is of polyclonal origin.
Landaas TO; Grimmer O; Heier HE; Godal T
Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):377-80. PubMed ID: 121023
[TBL] [Abstract][Full Text] [Related]
19. The immediate effects of splenectomy, radiotherapy and intensive chemotherapy on the immune status of patients with malignant lymphoma.
Hancock BW; Bruce L; Ward AM; Richmond J
Clin Oncol; 1977 Jun; 3(2):137-44. PubMed ID: 872467
[No Abstract] [Full Text] [Related]
20. Splenectomy and susceptibility to infection in childhood Hodgkin's disease.
Breuel K; Blau HJ
Neoplasma; 1984; 31(6):727-30. PubMed ID: 6521799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
